Search

Author/Creator Eisner, Mark

4. Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials. Issue 10 (October 2016)

Authors:
Hanania, Nicola A; Korenblat, Phillip; Chapman, Kenneth R; Bateman, Eric D; Kopecky, Petr; Paggiaro, Pierluigi; Yokoyama, Akihito; Olsson, Julie; Gray, Sarah; Holweg, Cecile T J; Eisner, Mark; Asare, Charles; Fischer, Saloumeh K; Peng, Kun; Putnam, Wendy S; Matthews, John G
Journal:
Lancet
Issue:
Volume 4:Issue 10(2016)
Page Start:
781
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Model‐based approach for methoxy polyethylene glycol‐epoetin beta drug development in paediatric patients with anaemia of chronic kidney disease. Issue 4 (21st January 2020)

Authors:
Chanu, Pascal; Schaefer, Franz; Warady, Bradley A.; Schmitt, Claus Peter; Reigner, Bruno; Schnetzler, Gabriel; Meyer Reigner, Sylvie; Eisner, Mark; Weichert, Arlette; Frey, Nicolas
Journal:
British journal of clinical pharmacology
Issue:
Volume 86:Issue 4(2020)
Page Start:
801
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗